您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Brief News on Innovation
Company News Brief News on Innovation
PEIJIA MEDICAL RECEIVES THE NMPA APPROVAL FOR THE REGISTRATION APPLICATION OF TaurusMax™ TAVR SYSTEM
2024-08-15 14:43:28

Peijia Medical received the NMPA approval for the registration application of TaurusMax™ in August 15, 2024. TaurusMaxTM is an iteration of TaurusElite®, with the following advantages: 

1) Commissural Alignment: ensuring proper alignment of the commissures to protect the coronary artery pathways, safeguarding the patients’ entire life cycle; 

2) Vision+ Marker: a clear visualization ring at the base for accurate judgment of implantation depth; 3) A2 FlexTM Dual-Axis Bending: optimizing coaxiality for precise implantation.

企业微信截图_20240826111330.png


Top